ADVFN - Advanced Financial Network.
HOME» NYSE » G » GSK Stock Price » GSK Stock News

Glaxosmithkline Share News

 Glaxosmithkline Stock Price
GSK Stock Price
 Glaxosmithkline Stock Chart
GSK Stock Chart
 Glaxosmithkline Stock News
GSK Stock News
 Glaxosmithkline Company Information
GSK Company Information
 Glaxosmithkline Stock Trades
GSK Stock Trades

GlaxoSmithKline Buys Back 1.1 Million Shares

LONDON--GlaxoSmithKline PLC (GSK.LN) Friday said it purchased 1.05 million ordinary shares on Aug. 24. MAIN FACTS: -Highest price paid per Share was 1,467.0 pence per share. -Lowest price paid per Share was 1459.0 pence per share. -Intends to hold these Shares in Treasury. -Shares on Friday closed at 1461 pence. -Write to Tapan Panchal at tapan.panchal@dowjones.com Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stock News for Glaxosmithkline (GSK)
DateTimeHeadline
05/13/201312:23:02LONDON MARKETS: GSK, Shell Lead U.K. Stocks To 8th Day Of Gains
05/13/201312:20:08EUROPE MARKETS: Europe Stocks Retreat From 2013 High
05/13/201306:00:08Elan Signs $1 Billion Drug Deal
05/13/201302:49:14Elan, Theravance Enter Into $1.0 Billion Royalty Participation...
05/10/201312:42:15GSK, Theravance See Breo Ellipta Available in 3Q13 After FDA...
05/10/201312:30:03FDA OKs GlaxoSmithKline Drug to Treat Lung Disease
05/10/201312:16:57FDA Approves GlaxoSmithKline's Breo Ellipta to Treat Lung Disease
05/01/201314:37:35Companies Serving Consumers in India Are M&A Targets
05/01/201308:10:24GlaxoSmithKline Gets 3 Month Extension to Trametinib PDUFA Goal...
04/30/201308:34:42GlaxoSmithKline Files Drug Application for UMEC in US
04/29/201308:42:08GSK, Impax End Collaboration on IPX066 Parkinson's Treatment
04/26/201305:35:08GlaxoSmithKline Makes EU Regulatory Submission For UMEC
04/25/201305:40:23Mixed Results for Drug Companies
04/25/201305:39:04LONDON MARKETS: U.K. Stocks Decline, Shrug Off GDP Data
04/24/201309:32:19MARKET COMMENT: London Stocks Recover Despite Downbeat US Data
04/24/201307:48:40GlaxoSmithKline 1Q Operating Profit Down 26%, Raises Dividend...
04/23/201307:29:16Amarin Says FDA Accepts Supplemental New Drug Application for...
04/22/201317:50:32Glaxo in Drug-Discovery Venture Capital Deal
04/19/201305:23:35GSK Responds to OFT Paroxetine Allegations, Says It Acted Lawfully
04/19/201302:43:44OFT Alleges GlaxoSmithKline Concluded Pacts Which Infringed Competition...

Glaxosmithkline and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad